HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cancer chemopreventive activity of the prenylated coumarin, umbelliprenin, in vivo.

Abstract
Umbelliprenin is a prenylated compound, which belongs to the class of sesquiterpene coumarins. In continuation of our earlier in-vitro finding, we determined to assess the cancer chemopreventive activity of umbelliprenin in vivo by using a two-stage carcinogenesis assay of mouse skin tumors induced by peroxynitrite as an initiator and TPA (12-O-tetradecanoylphorbol-13-acetate) as a promoter. In this assay, treatment with umbelliprenin along with peroxynitrite/TPA delayed the formation of papillomas up to week 9, and approximately 33.3 and 86.6% of the mice bore papillomas after 11 and 20 weeks of promotion, respectively. Umbelliprenin reduced the number of tumors per mouse by 45% after 20 weeks of promotion compared with the control group. Interestingly, this is equal to the corresponding value (45%) for curcumin, used as a reference standard compound in our study. In addition, the pattern of tumor promotion was slower in mice treated with umbelliprenin compared with the curcumin. Therefore, umbelliprenin might be valuable as a cancer chemopreventive agent.
AuthorsMehrdad Iranshahi, Amirhossein Sahebkar, Midori Takasaki, Takao Konoshima, Harukuni Tokuda
JournalEuropean journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) (Eur J Cancer Prev) Vol. 18 Issue 5 Pg. 412-5 (Sep 2009) ISSN: 1473-5709 [Electronic] England
PMID19531956 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticarcinogenic Agents
  • Carcinogens
  • Umbelliferones
  • Peroxynitrous Acid
  • umbelliprenin
Topics
  • Animals
  • Anticarcinogenic Agents (therapeutic use)
  • Carcinogens
  • Disease Models, Animal
  • Female
  • Mice
  • Papilloma (chemically induced, prevention & control)
  • Peroxynitrous Acid
  • Skin Neoplasms (chemically induced, prevention & control)
  • Umbelliferones (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: